$5.50
6.80% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
KYG596651029
Symbol
MGTX
Sector
Industry

MeiraGTx Holdings plc Stock price

$5.50
-0.15 2.65% 1M
-0.32 5.50% 6M
-0.59 9.69% YTD
-0.04 0.72% 1Y
-3.21 36.85% 3Y
-9.49 63.31% 5Y
-9.50 63.33% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.35 6.80%
ISIN
KYG596651029
Symbol
MGTX
Sector
Industry

Key metrics

Market capitalization $442.01m
Enterprise Value $456.37m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 13.22
P/S ratio (TTM) P/S ratio 12.81
P/B ratio (TTM) P/B ratio 13.20
Revenue growth (TTM) Revenue growth 203.23%
Revenue (TTM) Revenue $34.51m
EBIT (operating result TTM) EBIT $-159.04m
Free Cash Flow (TTM) Free Cash Flow $-109.57m
Cash position $66.52m
EPS (TTM) EPS $-2.31
P/E forward negative
P/S forward 4.12
EV/Sales forward 4.26
Short interest 4.71%
Show more

Is MeiraGTx Holdings plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

MeiraGTx Holdings plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a MeiraGTx Holdings plc forecast:

5x Buy
100%

Analyst Opinions

5 Analysts have issued a MeiraGTx Holdings plc forecast:

Buy
100%

Financial data from MeiraGTx Holdings plc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
35 35
203% 203%
100%
- Direct Costs 38 38
172% 172%
110%
-3.30 -3.30
30% 30%
-10%
- Selling and Administrative Expenses 25 25
28% 28%
74%
- Research and Development Expense 118 118
2% 2%
341%
-146 -146
6% 6%
-424%
- Depreciation and Amortization 13 13
9% 9%
37%
EBIT (Operating Income) EBIT -159 -159
5% 5%
-461%
Net Profit -167 -167
126% 126%
-485%

In millions USD.

Don't miss a Thing! We will send you all news about MeiraGTx Holdings plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

MeiraGTx Holdings plc Stock News

Neutral
GlobeNewsWire
7 days ago
Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx's Technology Platforms for Gene and Cell Therapy Multiple Poster Presentations Highlight the Depth and Novelty of MeiraGTx's Technology Platforms for Gene and Cell Therapy
Neutral
GlobeNewsWire
8 days ago
-  Announced strategic collaboration with Hologen AI, including a $200 million cash upfront payment to MeiraGTx and the formation of a joint venture, Hologen Neuro AI Ltd, with a further $230 million in capital committed to initially focus on expediting Phase 3 clinical development of AAV-GAD for Parkinson's disease -  U.S. Food and Drug Administration (FDA) Granted Regenerative Medicine Advanc...
Neutral
GlobeNewsWire
12 days ago
-  This RMAT designation is based on data from 3 clinical studies demonstrating the potential benefit of AAV-GAD as a one-time treatment for Parkinson's disease -  RMAT designation includes the benefits of the Fast Track and Breakthrough Therapy designations, allows frequent regulatory interactions with the FDA, and potential routes to accelerated approval and Priority Review LONDON and NEW YOR...
More MeiraGTx Holdings plc News

Company Profile

MeiraGTx Holdings Plc is a clinical-stage biotech company, which engages in the development of novel gene therapy treatments. It operates through the United States and United Kingdom geographical segments. Its pipeline includes AAV-CNGB3, AAV-CNGA3, AAV-RPE65, AAV-RPGR, AAV-AQP1 and AAV-UPF1. The company was founded on March 20, 2015 and is headquartered in New York, NY.

Head office Cayman Islands
CEO Alexandria Forbes
Employees 381
Founded 2015
Website www.meiragtx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today